Aditxt share price logo

Aditxt

OTC: ADTX

$0.00

+0.00

(+33.33%)

Live

as on

Aditxt Stock Performance

as on November 4, 2026 at 7:26 am IST

  • Day's Low

    Day's High

    $0.01
    $0.01
    downward going graph

    -2400.00%

    Downside

    2400.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.00
    $1,540.56
    downward going graph

    99.75%

    Downside

    385138700.00%

    Upside

    downward going graph

Aditxt share price movements today

Previous Close
$0.00
Open
$0.01
Volume
3.4M
Market Cap
$998.0K
Day's Low - High
$0.01 - $0.01
52 Week Low - High
$0.00 - $1,540.56

Aditxt Historical Returns

1 Month Return
-90.62 %
3 Month Return
-89.29 %
1 Year Return
-100 %
3 Year Return
-100 %
5 Year Return
-100 %

Aditxt Stock Fundamentals & Key Indicators

Check Aditxt market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$998.0K

EPS (TTM)

-1490.72

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

Industry PE ratio

-4.50

PEG Ratio

0.00

EBITDA

-50.7M

Revenue (TTM)

14.3K

Profit Margin

19.89%

Return On Equity TTM

926.02%

Aditxt vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aditxt with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Aditxt image
Aditxt
Hold$998.0K-100.00%NA19.89%0.00%
Alnylam Pharma image
Alnylam Pharma
StrongBuy$22.1B-1.58%8.1077.28%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$141.7B192.56%32.2786.04%0.00%
Regeneron image
Regeneron
Buy$95.5B47.41%19.7685.77%0.40%

Stock Returns calculator for Aditxt Stock including INR - Dollar returns

The Aditxt stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Aditxt investment value today

Current value as on today

₹0

Returns

-₹1,00,000

(-100%)

Returns from Aditxt Stock

-₹1,00,000 (-100%)

Dollar Impact

₹0 (+0.00%)

Analyst Recommendation on Aditxt Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for Aditxt. Average target price of $61

Aditxt Share Price Target

Get share price movements and forecasts by analysts on Aditxt.

What analysts predicted

100%UPSIDE

Target Price

$61

Current Price

$0.0004

Analyzed by

6 Analysts

Target

$61.00

Aditxt target price $61, a slight upside of 100% compared to current price of $0.0004. According to 6 analysts rating.

Indian Investors' Interest in Aditxt Stock

Search interest for Aditxt Stock has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:17% versus previous 30 day period

Aditxt Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-7
-11
-5
-4
-5
-5
-6
-3
-4
-4
EBITDA
-7
-11
-5
-4
-5
-5
-6
-23
-4
-16
Interest Expense
3
3
1
2
0
0
1
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-14
-7
-6
-5
-5
-7
-24
-5
-16
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-10
-14
-7
-6
-5
-5
-7
-24
-4
-15
Net Profit Margin
-251.63%
17.42%
47.75%
-6721.36%
-2136.38%
27.90%
-0.10%
2.14%
-7.29%
23.59%

Aditxt Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
0
0
0
0
0
Gross Profit
-
-
-
0
0
0
0
0
0
Operating Income
0
-5
-5
-8
-41
-25
-26
-27
-19
EBITDA
0
0
0
-8
-43
-24
-25
-27
-40
Interest Expense
-
0
0
0
1
2
6
7
2
Depreciation
0
5
5
0
0
0
0
0
0
Income Before Tax
0
-5
-5
-9
-46
-27
-32
-35
-42
Income Tax Expense
0
-
-
-
-
-
-
-
-
Net Income
0
-5
-5
-9
-46
-27
-32
-34
-41
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
25.76%
17.88%
-17.31%
-367.95%
8.39%

Aditxt Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-10
-14
-7
-6
-5
-5
-7
-24
-5
-16
Operating Cash Flow
-3
-5
-2
-2
-6
-11
-2
-2
-9
-4
Investing Cash Flow
-
-
-1
-1
-2
-
-2
-
0
0
Financing Cash Flow
1
5
3
3
9
11
4
2
12
1
Change in Cash
-1
0
0
0
0
0
0
0
3
-2

Aditxt Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-5
-5
-9
-46
-27
-32
-34
-42,787
Operating Cash Flow
-
0
0
-7
-22
-22
-18
-16
-25,688
Investing Cash Flow
-
-
-
0
-16
0
0
-5
-2,438
Financing Cash Flow
0
0
0
17
35
17
16
22
30,492
Change in Cash
0
0
0
10
-2
-5
-2
0
2,365

Global Institutional Holdings in Aditxt

Check out the Institutions with significant holdings in Aditxt.

Funds
Holdings
Wey Ann Tai
0.01%
Bank Of America Corp De
0.00%
Brady Brian Michael
0.00%

Aditxt News & Key Events

    Insights on Aditxt

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 425.0 → 12.15K (in $), with an average increase of 96.5% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.8% return, outperforming this stock by 119.8%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Aditxt, Inc. Common Stock has experienced a drawdown of -100.0%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 80.0%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 1 month, ADTX stock has moved down by -98.2%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, -4.70M → -15.94M (in $), with an average decrease of 239.2% per quarter

    About Aditxt

    Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques. The company's developments include AditxtScore, a platform designed to empower individuals by providing insights into their immune profiles for better management and informed awareness of immune system attacks or dysfunctions. Aditxt also pioneers Apoptotic DNA Immunotherapy, a nucleic acid-based solution that emulates the body's inherent mechanisms for developing self-tolerance to its own tissues. Additionally, Aditxt is actively researching and developing ADi products with diverse therapeutic applications, such as for organ transplant procedures (including skin grafting), various autoimmune conditions, and allergic reactions. The company holds licensing agreements with esteemed institutions like Loma Linda University and Leland Stanford Junior University. Established in 2017, this Richmond, Virginia-headquartered company was initially known as ADiTx Therapeutics, Inc. before rebranding to Aditxt, Inc. in July 2021.
    OrganisationAditxt
    Headquarters2569 Wyandotte Street, Mountain View, CA, 94043, US
    IndustryBiotechnology
    CEOJeffrey Busch

    Key Management of Aditxt

    Name

    Title

    Mr. Jeffrey M. Busch J.D.

    Chief Executive Officer

    Dr. Dolly B. Tyan D(ABHI), Ph.D.

    Senior Vice President of Clinical Development ? Transplantation

    Mr. Ge Chen M.D., M.S.

    Senior Vice President of Preclinical Research & Discovery

    Ms. Jennifer Lee

    Director of Human Resources

    Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D.

    Co-Founder, Chief Innovation Officer & Secretary

    Mr. Thomas J. Farley CPA

    Chief Financial Officer

    Ms. Corinne D. Pankovcin CPA, M.B.A.

    Chief Mergers & Acquisitions Officer

    FAQs

    What is Aditxt share price today?

    Aditxt share price today is $0.00 as on . Aditxt share today touched a day high of $0.01 and a low of $0.01.

    What is the 52 week high and 52 week low for Aditxt share?

    Aditxt share touched a 52 week high of $1,540.56 on and a 52 week low of $0.00 on . Aditxt stock price today i.e. is trending at $0.00,which is 100.00% down from its 52 week high and 39900.00% up from its 52 week low.

    What is Aditxt's market capitalisation today?

    Aditxt market capitalisation is $0.00T as on .

    How to invest in Aditxt Stock (ADTX) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Aditxt on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy Aditxt Stock (ADTX) from India?

    Indian investors can start investing in Aditxt (ADTX) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹947.40 in Aditxt stock (as per the Rupee-Dollar exchange rate as on ). Based on Aditxt share’s latest price of $0.00 as on November 4, 2026 at 1:56 am IST, you will get 25000.0000 shares of Aditxt. Learn more about fractional shares .

    What are the returns that Aditxt has given to Indian investors in the last 5 years?

    Aditxt stock has given -100% share price returns and 27.47% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?